IL202002A0 - Method of treating diabetes - Google Patents
Method of treating diabetesInfo
- Publication number
- IL202002A0 IL202002A0 IL202002A IL20200209A IL202002A0 IL 202002 A0 IL202002 A0 IL 202002A0 IL 202002 A IL202002 A IL 202002A IL 20200209 A IL20200209 A IL 20200209A IL 202002 A0 IL202002 A0 IL 202002A0
- Authority
- IL
- Israel
- Prior art keywords
- treating diabetes
- diabetes
- treating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2007/070140 WO2008147417A1 (en) | 2007-05-31 | 2007-05-31 | Method of treating diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
IL202002A0 true IL202002A0 (en) | 2010-06-16 |
Family
ID=38812044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL202002A IL202002A0 (en) | 2007-05-31 | 2009-11-09 | Method of treating diabetes |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP2152268A1 (en) |
JP (1) | JP2010528112A (en) |
KR (1) | KR20100038322A (en) |
CN (1) | CN101678017A (en) |
AU (1) | AU2007354300A1 (en) |
BR (1) | BRPI0721741A2 (en) |
CA (1) | CA2687381A1 (en) |
IL (1) | IL202002A0 (en) |
MX (1) | MX2009012957A (en) |
NO (1) | NO20093592L (en) |
WO (1) | WO2008147417A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003248558B8 (en) | 2002-05-21 | 2009-07-09 | Gilead Sciences, Inc. | Method of treating diabetes |
US8822473B2 (en) | 2002-05-21 | 2014-09-02 | Gilead Sciences, Inc. | Method of treating diabetes |
US20090111826A1 (en) * | 2007-02-13 | 2009-04-30 | Louis Lange | Use of ranolazine for the treatment of cardiovascular diseases |
RU2691620C1 (en) * | 2018-11-26 | 2019-06-14 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Астраханский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Астраханский ГМУ Минздрава России) | Method for prediction of the risk of developing ischemic heart disease in patients with type 2 diabetes mellitus combined with subclinical thyrotoxicosis |
CN110812344A (en) * | 2019-12-17 | 2020-02-21 | 卓和药业集团有限公司 | Pharmaceutical composition for treating diabetes complicated with angina pectoris and preparation method thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6479496B1 (en) * | 1998-09-10 | 2002-11-12 | Cv Therapeutics, Inc. | Methods for treating angina with ranolazine |
AU2003248558B8 (en) * | 2002-05-21 | 2009-07-09 | Gilead Sciences, Inc. | Method of treating diabetes |
RU2384332C2 (en) * | 2005-01-06 | 2010-03-20 | Си Ви Терапьютикс, Инк. | Prolonged release pharmaceutical preparative forms |
-
2007
- 2007-05-31 JP JP2010510275A patent/JP2010528112A/en active Pending
- 2007-05-31 AU AU2007354300A patent/AU2007354300A1/en not_active Abandoned
- 2007-05-31 KR KR1020097027359A patent/KR20100038322A/en not_active Application Discontinuation
- 2007-05-31 CN CN200780053142A patent/CN101678017A/en active Pending
- 2007-05-31 WO PCT/US2007/070140 patent/WO2008147417A1/en active Search and Examination
- 2007-05-31 CA CA002687381A patent/CA2687381A1/en not_active Abandoned
- 2007-05-31 EP EP07797962A patent/EP2152268A1/en not_active Withdrawn
- 2007-05-31 MX MX2009012957A patent/MX2009012957A/en not_active Application Discontinuation
- 2007-05-31 BR BRPI0721741-2A patent/BRPI0721741A2/en not_active IP Right Cessation
-
2009
- 2009-11-09 IL IL202002A patent/IL202002A0/en unknown
- 2009-12-23 NO NO20093592A patent/NO20093592L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20100038322A (en) | 2010-04-14 |
MX2009012957A (en) | 2010-03-03 |
JP2010528112A (en) | 2010-08-19 |
BRPI0721741A2 (en) | 2013-02-13 |
EP2152268A1 (en) | 2010-02-17 |
CN101678017A (en) | 2010-03-24 |
NO20093592L (en) | 2010-01-20 |
AU2007354300A1 (en) | 2008-12-04 |
CA2687381A1 (en) | 2008-12-04 |
WO2008147417A1 (en) | 2008-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190408T1 (en) | Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof | |
IL212348A0 (en) | Treatment method | |
EP2032131A4 (en) | Method of treatment | |
PL2190883T3 (en) | Biomass treatment method | |
HK1148435A1 (en) | Oxadiazoanthracene compounds for the treatment of diabetes | |
IL208354A0 (en) | Methods of treatment | |
EP2174912A4 (en) | Method of treating copper-arsenic compound | |
GB0610746D0 (en) | Method of treatment | |
EP2350641A4 (en) | Method of treatment | |
IL200769A (en) | Method of treating potash | |
PL2441462T3 (en) | Method for treating type I diabetes | |
EP2144886A4 (en) | Method of treating melanoma | |
IL202002A0 (en) | Method of treating diabetes | |
GB0718684D0 (en) | Treatment method | |
EP2164494A4 (en) | Methods of treatment | |
EP2498794A4 (en) | Method of treatment of type 2 diabetes | |
ZA201007680B (en) | Method of treating metalliferrous materials | |
EP2162021A4 (en) | Method of treating foodstuff | |
EP2203432A4 (en) | Method of treatment | |
GB0717337D0 (en) | Method of treatment | |
ZA200907778B (en) | Method of treating diabetes | |
GB0823435D0 (en) | Method of treatment | |
GB0618227D0 (en) | Novel method of treatment | |
ZA201102198B (en) | Treatment method | |
GB0802903D0 (en) | Treatment of diabetes |